Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report.

about

Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report.

Item

http://www.wikidata.org/entity/Q36882557

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Severe hypophosphatemia induce ...... kin's lymphoma: a case report.

@en

type

Item

label

Severe hypophosphatemia induce ...... kin's lymphoma: a case report.

@en

prefLabel

Severe hypophosphatemia induce ...... kin's lymphoma: a case report.

@en

P1476

Severe hypophosphatemia induce ...... gkin's lymphoma: a case report

@en

P2093

Hager A El-Geed

http://www.w3.org/2001/XMLSchema#string

Sumaya Al Yafei

http://www.w3.org/2001/XMLSchema#string

P2860

Severe hypomagnesaemia with tetany following ESHAP protocol

Red cell 2,3-diphosphoglycerate and oxygen affinity.

A method for estimating the probability of adverse drug reactions

Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.

ESHAP is an active regimen for relapsing Hodgkin's disease.

Life threatening hypophosphataemia in a patient with Philadelphia chromosome-positive chronic myelogenous leukaemia in acute blastic crisis.

Science behind cisplatin-induced nephrotoxicity in humans: a clinical study.

Medication-induced hypophosphatemia: a review.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.2147/IMCRJ.S37286

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shereen Elazzazy

P577

2013-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23750103

http://www.w3.org/2001/XMLSchema#string

P932

3666155

http://www.w3.org/2001/XMLSchema#string